Group, Chao AM, Wadden TA, et al
Significant weight regain was observed in both subgroups (WMD = 1.45 kg, 95% CI 0.62 to 2.28, P = 0.006, I 2 = 72%
Our findings suggest that compared to insulin therapy, the higher drug acquisition, pharmacy, and outpatient costs associated with the real-world use of a GLP-1RA is offset by a reduction in healthcare-related expenses associated with emergency room visits and inpatient admissions owing to reduced risks of all-cause mortality and hospitalized hypoglycemia
Given the recent results of the CREDENCE trial, many patients will also be treated with an SGLT2-inhibitor, allowing the trial to study the combined use of these agents on renal outcomes
How L-Carnitine Enhances the Keto Diet 1
While today's medications may be becoming more affordable, newer therapies are expected to enter the market that may offer greater efficacy , but come with higher costs